Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Rab27a: a new face in β cell metabolism-secretion coupling
Toru Aizawa, Mitsuhisa Komatsu
Toru Aizawa, Mitsuhisa Komatsu
Published February 1, 2005
Citation Information: J Clin Invest. 2005;115(2):227-230. https://doi.org/10.1172/JCI24269.
View: Text | PDF
Commentary

Rab27a: a new face in β cell metabolism-secretion coupling

  • Text
  • PDF
Abstract

In pancreatic β cells, not only insulin exocytosis per se, but translocation of β granules toward the plasma membrane — an event upstream of exocytosis — are under the control of glucose. However, the molecular basis of this translocation has been poorly understood. Rab27a-mediated translocation of glucose-induced β granules is reported in this issue of the JCI. Rab27a or its effector molecule may constitute a novel pharmacological target because potentiation of the Rab27a pathway is expected to restore β cell glucose competency in patients with diabetes mellitus.

Authors

Toru Aizawa, Mitsuhisa Komatsu

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
A schematic presentation of glucose-induced biphasic insulin secretion b...
A schematic presentation of glucose-induced biphasic insulin secretion by islet β cells. Stimulation by a high concentration of glucose elicits a rapid increase in insulin secretion within 1–2 minutes (first phase). Within 10 minutes, in the presence of the same stimulatory concentration of glucose, the secretion rate is decreased, and it gradually begins to increase again thereafter (second phase). Second-phase insulin release is more prominent in rat and human than in mouse β cells. First-phase insulin release is generated by fusion of β granules already in the RRP and the plasma membrane, which is called triggering. For the second phase, granules translocate from the RP to the RRP, which yields expansion and/or replenishment of the RRP. The first and second phases of insulin secretion are due to KATP channel–dependent and –independent glucose signaling, respectively, as outlined in Figure 1.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts